POET-SHIELD

Summary

The POET-SHIELD study collects detailed information about participants' cancer biology, health, and lifestyle. By collecting biological samples, we will be able to conduct molecular analysis on these samples to determine targets for treatment and how these targets may change during treatment, or at recurrence and progression of disease. Identifying potential molecular targets can greatly impact the development of new treatments in hopes of improving survival outcomes for cancer patients.

Through the POET-SHIELD study, the POET Program will play a key role in developing a personalized approach to treatment planning as well as facilitating the timely adoption of new therapies.

If you choose to participate, your information will be pooled with a very large group of other cancer patients in Alberta. Through this program, we aim to benefit the scientific community through access to clinical data and biological samples for research purposes in hopes of improving treatments and survival outcomes for cancer patients within the community.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 100

Inclusion criteria:

In order to participate in the study, you must satisfy all of the following eligibility criteria:
1) Pathologically or clinically confirmed diagnosis of cancer.
2) Be at least 18 years of age.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

For more information, or to join the study, please contact Tracy Xu at tracy.xu@ahs.ca

Principal investigator:

Steven Yip

Clinical trial:

No

REB-ID:

HREBA.CC-16-0956